Key result
Pharmacist-led anticoagulation monitoring increased the percentage of time within the target INR range compared to usual care in hospitalized patients receiving warfarin.
Why the study?
The study was conducted to investigate the role of a pharmacist-led anticoagulation monitoring service for warfarin therapy in patients during hospitalization.
Does daily pharmacist-led anticoagulation monitoring improve the effectiveness and safety of warfarin in hospitalized patients?
Cohort (n=421)
No
Does daily pharmacist-led anticoagulation monitoring improve the effectiveness and safety of warfarin in hospitalized patients?
Pharmacist-led anticoagulation monitoring during hospitalization may improve the effectiveness and safety of warfarin therapy.
Answers are grounded in this paper and cite their sources.
May support pharmacist involvement in warfarin care; hypothesis-generating and should not yet change practice without RCTs.
OBJECTIVE: To investigate the role of pharmacist-led anticoagulation monitoring service for warfarin anticoagulation therapy in patients during hospitalization. METHODS: We retrospectively analyzed the data of 421 patients receiving warfarin anticoagulation therapy during hospitalization between April, 2016 and December, 2017. Of these patients, 316 received daily pharmacist-led anticoagulation monitoring service including checking the patients' International Normalized Ratio (INR) and other pertinent laboratory test results and reviewing medication changes and the patients' clinical status (monitoring group); the other 105 patients receiving warfarin anticoagulation therapy without pharmaceutical care served as the control group. The data including compliance rate of anticoagulant indicators, incidence and rate of prompt management of INR alert, thrombosis and bleeding events during hospitalization were analyzed among these patients. CONCLUSIONS: Pharmacist-led anticoagulation monitoring service can significantly improve the effectiveness and safety of warfarin anticoagulation therapy for patients during hospitalization.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2020) conducted a cohort in Patients requiring warfarin anticoagulation therapy (n=421). Pharmacist-led anticoagulation monitoring vs. Usual care without pharmaceutical care was evaluated on Percentage time within target INR range (TTR) (p=<0.001). Pharmacist-led anticoagulation monitoring increased the percentage of time within the target INR range compared to usual care in hospitalized patients receiving warfarin.
Synapse has enriched 10 related papers. Consider them for comparative context: